These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 22564014

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Inhaled mannitol for the treatment of cystic fibrosis.
    Hurt K, Bilton D.
    Expert Rev Respir Med; 2012 Feb; 6(1):19-26. PubMed ID: 22283575
    [Abstract] [Full Text] [Related]

  • 5. Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis: effect on lung function, health status and sputum.
    Daviskas E, Anderson SD, Gomes K, Briffa P, Cochrane B, Chan HK, Young IH, Rubin BK.
    Respirology; 2005 Jan; 10(1):46-56. PubMed ID: 15691238
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Beneficial effect of inhaled mannitol and cough in asthmatics with mucociliary dysfunction.
    Daviskas E, Anderson SD, Eberl S, Young IH.
    Respir Med; 2010 Nov; 104(11):1645-53. PubMed ID: 20576419
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inhaled mannitol in patients with cystic fibrosis: A randomised open-label dose response trial.
    Teper A, Jaques A, Charlton B.
    J Cyst Fibros; 2011 Jan; 10(1):1-8. PubMed ID: 20888307
    [Abstract] [Full Text] [Related]

  • 11. Phase 3 randomized study of the efficacy and safety of inhaled dry powder mannitol for the symptomatic treatment of non-cystic fibrosis bronchiectasis.
    Bilton D, Daviskas E, Anderson SD, Kolbe J, King G, Stirling RG, Thompson BR, Milne D, Charlton B, B301 Investigators.
    Chest; 2013 Jul; 144(1):215-225. PubMed ID: 23429964
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Mucoactive agents for chronic, non-cystic fibrosis lung disease: A systematic review and meta-analysis.
    Tarrant BJ, Le Maitre C, Romero L, Steward R, Button BM, Thompson BR, Holland AE.
    Respirology; 2017 Aug; 22(6):1084-1092. PubMed ID: 28397992
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inhaled hyperosmolar agents for bronchiectasis.
    Wills P, Greenstone M.
    Cochrane Database Syst Rev; 2006 Apr 19; (2):CD002996. PubMed ID: 16625566
    [Abstract] [Full Text] [Related]

  • 16. Pharmacologic agents for mucus clearance in bronchiectasis.
    Nair GB, Ilowite JS.
    Clin Chest Med; 2012 Jun 19; 33(2):363-70. PubMed ID: 22640851
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The efficacy of inhaled antibiotics in non-cystic fibrosis bronchiectasis.
    Amaro R, Panagiotaraka M, Alcaraz V, Torres A.
    Expert Rev Respir Med; 2018 Aug 19; 12(8):683-691. PubMed ID: 30010445
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.